Non-Invasive Prenatal Testing (NIPT) screens for chromosomal abnormalities using foetal DNA in the mother’s bloodstream. Performed from the 9th week (Panorama) or the 10th week (RapidNIPT), with no risk to mother or baby.
What Does NIPT Screen For?
Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), Trisomy 13 (Patau’s syndrome), sex chromosome abnormalities, and — with extended panels — microdeletions.
Who Should Consider NIPT?
Women aged 35+, personal or family history of chromosomal conditions, pregnancies following IVF, abnormal first trimester combined screening result.
Accuracy
Detection rate over 99% for Trisomy 21. NIPT is a screening test — positive results require confirmatory diagnostic testing (CVS or amniocentesis).
The Process
Simple maternal blood draw. Results are typically available within 5–10 working days, depending on the panel.
To arrange NIPT as part of your antenatal care with Assist. Prof. Dr. Muzaffer Uçarer, contact UCARER Women’s Health.
Prices
- Genoks RapidNIPT — €420 — Trisomy 21, 18, 13; sex-chromosome and selected microdeletion options depending on the panel
- Panorama NIPT — €540 — Trisomy 21, 18, 13, sex-chromosome count and triploidy
- Panorama Plus — €590 — the above + 22q11.2 (DiGeorge) microdeletion
- Panorama Full — €660 — the above + 1p36, Angelman, Cri-du-chat, Prader-Willi and XXX/XXY/XYY
Twin pregnancies are charged at the same price as the corresponding single-baby panel. Reporting the baby’s sex is optional and included.
Our medical prices are fixed; your exact, all-inclusive price is confirmed in writing after your consultation. See our full price list →
Fetal anomaly screening at UCARER, Bahçeşehir: our approach
At UCARER Women’s Health in Bahçeşehir (Başakşehir), Istanbul, fetal anomaly screening is a structured, non-invasive protocol offered to every pregnancy, overseen by two experienced obstetrician–gynaecologists, Assist. Prof. Dr. Muzaffer Uçarer and Op. Dr. Meryem Gökkaya Uçarer. The protocol combines:
- The first-trimester combined (“dual”) test — a blood test plus nuchal translucency ultrasound, usually between weeks 11 and 14.
- NIPT (non-invasive prenatal testing) — a maternal blood test that assesses the risk of common chromosomal conditions with high accuracy and no risk to the baby.
- Around the 20th week, a detailed fetal anomaly ultrasound that examines the baby’s anatomy in detail, together with a perinatology consultation from a professor-level perinatology specialist for every patient.
NIPT and the combined test — how they differ
The combined (dual) test estimates risk from ultrasound and blood markers; NIPT analyses cell-free fetal DNA in the mother’s blood and gives a more precise risk assessment for conditions such as Down syndrome. Both are screening tests: when a result indicates higher risk, your obstetrician discusses the next steps with you. If a pregnancy needs closer follow-up, see our high-risk pregnancy care.
Frequently asked questions
Is NIPT safe for the baby? Yes. NIPT is a simple maternal blood test and carries no risk to the baby.
What is the difference between NIPT and the dual test? The dual test combines ultrasound and blood markers to estimate risk in the first trimester; NIPT analyses fetal DNA in the mother’s blood for a more precise risk assessment. Your obstetrician advises which is appropriate for you.
When is the detailed anomaly scan done? Around the 20th week; at UCARER it is offered to every patient together with a perinatology consultation from a professor-level specialist.
Do these tests diagnose a condition? They are screening tests that assess risk. If risk is higher, your obstetrician will discuss further diagnostic options with you.
Which NIPT panel is right for you?
We work with two laboratories and four panels, so the test can be matched to what you actually want screened. Panorama (Natera) is an SNP-based test that can be performed from the 9th week of pregnancy, with the result about 5–7 days after the sample reaches the laboratory; it is the only NIPT that also screens for triploidy. Genoks RapidNIPT is a cell-free DNA test performed from the 10th week, run in a laboratory licensed by the Turkish Ministry of Health.
- Panorama NIPT — Trisomy 21, 18 and 13, sex-chromosome count and triploidy.
- Panorama Plus — the above plus the 22q11.2 (DiGeorge) microdeletion.
- Panorama Full — the above plus 1p36, Angelman, Cri-du-chat and Prader-Willi microdeletions, and XXX/XXY/XYY.
- Genoks RapidNIPT — Trisomy 21, 18 and 13, with sex-chromosome and selected microdeletion options depending on the panel.
Learning the baby’s sex is optional and entirely your choice.
NIPT in twin pregnancies
Panorama first determines whether the twins are identical (monozygotic) or fraternal (dizygotic) and measures the fetal fraction of each baby separately. For identical twins it screens Trisomy 21, 18 and 13, sex-chromosome aneuploidy and 22q11.2; triploidy and the other microdeletions are not available in identical twins. For fraternal twins it screens Trisomy 21, 18 and 13 only, and more than 10% of fraternal twin pregnancies may not produce a result because the fetal fraction is too low. Panorama is not validated for pregnancies using an egg donor or a gestational carrier. Your obstetrician will confirm which option fits your pregnancy.
Planning a pregnancy? Carrier screening comes first
NIPT looks at the baby during pregnancy. Before conception a different test answers a different question: carrier screening checks the parents for inherited conditions such as SMA and cystic fibrosis, and is best done before you start trying.
NIPT is a screening test, not a diagnosis. If a result comes back high-risk, our medical team stays with you and guides you through confirmatory testing such as CVS or amniocentesis.
Contact UCARER Women’s Health to book your consultation with Assist. Prof. Dr. Muzaffer Uçarer.